Cue Biopharma, . vs MacroGenics
Cue Biopharma, . vs MacroGenics, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cue Biopharma, . is on 62/100 and MacroGenics on 49/100.
Where each one leads
Cue Biopharma, .
- our overall score: 62/100 against 49/100
- agent readiness: 42/100 against 35/100
MacroGenics
- domain rating: 50/100 against 34/100
- funding raised: $13.5M against $10.0M
At a glance
| Measure | Cue Biopharma, . | MacroGenics |
|---|---|---|
| What it is | Developing engineered biologics to harness the immune system for disease treatment. | Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases. |
| Category | Biotech, Drug Discovery, Immunotherapy, Therapeutics | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Biotech | Software |
| Founded | 2017 | 2000 |
| Headquarters | Boston, United States | Rockville, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Cue Biopharma, . | MacroGenics |
|---|---|---|
| Employees | 38 | Not published |
| Total funding | $10.0M | $13.5M |
| Latest round | Seed | Series A |
| LinkedIn followers | 5,297 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cue Biopharma, . | MacroGenics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 49/100 |
| Traction | Not published | 36/100 |
| Team | 60/100 | 70/100 |
| Search visibility | 67/100 | 12/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 34/100 | 50/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cue Biopharma, . | MacroGenics |
|---|---|---|
| Hosting | Not detected | Google Cloud |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Tailwind CSS | Jquery |
| Analytics | Google Analytics 4 | Google Analytics 4 |
Cue Biopharma, . vs MacroGenics: common questions
Which is better, Cue Biopharma, . or MacroGenics?
On our 0-100 score Cue Biopharma, . rates higher (62/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Cue Biopharma, . and MacroGenics compare on the numbers?
Cue Biopharma, . leads on our overall score (62/100 against 49/100), agent readiness (42/100 against 35/100). MacroGenics leads on domain rating (50/100 against 34/100), funding raised ($13.5M against $10.0M).
Read the full Cue Biopharma, . review and pricing or the MacroGenics review and pricing. You can also browse other Cue Biopharma, . alternatives we track.